Protection SSCB is a service dedicated to families who have stored their child’s stem cells with our bio bank. This service was created to provide the child and the whole family with greater security in the event of the sample being returned for a possible transplant.
Continue reading
SSCB from this year, thanks also to its GMP (Good Manufacturing Practice) certification, offers a new service to its customers, giving the possibility to store stem cells from adipose tissue for potential future use.
Continue reading
In 2021, SSCB is pleased to announce the opening of new offices in Zurich and Rome, thanks to the achievement of many new milestones, such as the collaboration with the Swiss Stem Cells Foundation (SSCF).
Continue reading
n this experimental study, a protocol was developed for processing a formulation derived from secretome obtained from adipose tissue mesenchymal stem cells at different concentrations. Its molecular composition and in vitro efficacy was evaluated when applied to breast cancer cell lines. In addition, the ability of the formulation to suppress the growth of triple-negative breast cancer when infused into a mouse model of the disease was verified.
Continue reading
Current therapies do not induce significant benefits in chronic stroke patients. Preclinical studies suggest that autologous transplantation of adipose tissue stem cells may be of benefit. This phase one clinical trial was developed to test the safety and efficacy of adipose tissue mesenchymal stem transplantation in chronic stroke patients.
Continue reading
To date, the immunomodulatory capacity of mesenchymal stem cells is well known. In this phase one clinical trial, the efficacy of these cells for the treatment of refractory lupus nephritis (LN) was verified. Specifically, 9 patients received systemic infusion of mesenchymal stem cells derived from adipose tissue and followed up for a 12-month follow-up period.
Continue reading
group (n = 111) and cord blood mesenchymal stem cell infusion group (n = 108). Both groups were followed up for a follow-up period of 7 years (October 2010 to October 2017). Specifically, patients in the control group received only conventional therapy while patients in the other group received three infusions of mesenchymal stem cells from cord tissue at four-week intervals.
Continue reading
During pregnancy there is a physiological two-way exchange of cells between mother and foetus. Similarly, expectant mothers may have acquired cells from their mothers (GdM) and these latter cells may in turn be transferred to the fetus through the mother-fetus blood stream.
Continue reading
senchymal stem cells are able to induce a therapeutic effect when transplanted into an animal model of Alzheimer’s disease. Neprilysin (NEP) is the main enzyme responsible for the degradation of amyloid (Aβ).
Continue reading